Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eltrombopag”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Large-scale testing (Phase 3)Study completedNCT00529568
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 759
Testing effectiveness (Phase 2)Looking for participantsNCT04993885
What this trial is testing

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune ThrombocytopeniaAutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 52
Large-scale testing (Phase 3)Study completedNCT03939637
What this trial is testing

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT03206086
What this trial is testing

Eltrombopag for Fanconi Anemia

Who this might be right for
Fanconi Anemia
National Heart, Lung, and Blood Institute (NHLBI) 25
Not applicableStudy completedNCT06768619
What this trial is testing

Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State

Who this might be right for
Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 36
Not applicableStudy completedNCT01236014
What this trial is testing

Indirect Comparison Between Eltrombopag & Romiplostim

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT01520909
What this trial is testing

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Ended earlyNCT01113502
What this trial is testing

Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia (AML)
Abramson Cancer Center at Penn Medicine 44
Not applicableStudy completedNCT01439321
What this trial is testing

Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 280
Large-scale testing (Phase 3)Not Yet RecruitingNCT06493981
What this trial is testing

Outcomes in Bone Marrow Aplasia.

Who this might be right for
Aplastic Anemia Idiopathic
Assiut University 3
Not applicableAvailableNCT04837703
What this trial is testing

Managed Access Programs for ETB115, Eltrombopag

Who this might be right for
Thrombocytopenia
Novartis Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT03701217
What this trial is testing

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Who this might be right for
EltrombopagThrombocytopeniaAcute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 220
Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Study completedNCT04328727
What this trial is testing

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00922883
What this trial is testing

A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

Who this might be right for
Anemia, AplasticAnemia, HypoplasticThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 43
Not applicableStudy completedNCT01416311
What this trial is testing

Drug Use Investigation for REVOLADE (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
Novartis Pharmaceuticals 5,797
Testing effectiveness (Phase 2)Active Not RecruitingNCT04797000
What this trial is testing

Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Ended earlyNCT01821625
What this trial is testing

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

Who this might be right for
ThrombocytopeniaHepatitis C
University of Texas Southwestern Medical Center 7
Early research (Phase 1)Ended earlyNCT01550185
What this trial is testing

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more
Roswell Park Cancer Institute 10
Next Page